These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10644290)

  • 21. Effect of atorvastatin on lipoprotein (a) and interleukin-10: a randomized placebo-controlled trial.
    Hernández C; Francisco G; Ciudin A; Chacón P; Montoro B; Llaverias G; Blanco-Vaca F; Simó R
    Diabetes Metab; 2011 Apr; 37(2):124-30. PubMed ID: 21131223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Atorvastatin].
    Kajinami K; Takekoshi N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():598-604. PubMed ID: 11347138
    [No Abstract]   [Full Text] [Related]  

  • 23. Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin.
    Nawawi H; Osman NS; Annuar R; Khalid BA; Yusoff K
    Atherosclerosis; 2003 Aug; 169(2):283-91. PubMed ID: 12921980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of atorvastatin and atorvastatin withdrawal on soluble CD40L and adipocytokines in patients with hypercholesterolaemia.
    Chu CS; Lee KT; Lee MY; Su HM; Voon WC; Sheu SH; Lai WT
    Acta Cardiol; 2006 Jun; 61(3):263-9. PubMed ID: 16869445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensive statin treatment improves baroreflex sensitivity: another cardioprotective mechanism for statins?
    Patterson D; Dick JB; Struthers AD
    Heart; 2002 Oct; 88(4):415-6. PubMed ID: 12231607
    [No Abstract]   [Full Text] [Related]  

  • 26. Liptruzet: a combination of ezetimibe and atorvastatin.
    Med Lett Drugs Ther; 2013 Jun; 55(1419):49-50. PubMed ID: 23797796
    [No Abstract]   [Full Text] [Related]  

  • 27. [AVERT study (Atorvastatin Versus Revascularization Treatment). Clinical advantage of aggressive lipid lowering].
    Z Kardiol; 1999 Mar; 88(3 Suppl):1-4. PubMed ID: 10330699
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
    Pincus J
    Am J Cardiol; 1998 Aug; 82(3):406-7. PubMed ID: 9708683
    [No Abstract]   [Full Text] [Related]  

  • 29. Atorvastatin calcium: an addition to HMG-CoA reductase inhibitors.
    Chong PH; Seeger JD
    Pharmacotherapy; 1997; 17(6):1157-77. PubMed ID: 9399600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atorvastatin--a new lipid-lowering drug.
    Med Lett Drugs Ther; 1997 Mar; 39(997):29-31. PubMed ID: 9121394
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of atorvastatin on plasma fibrinogen.
    Wierzbicki AS; Lumb PJ; Semra YK; Crook MA
    Lancet; 1998 Feb; 351(9102):569-70. PubMed ID: 9492781
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment with atorvastatin improves small artery compliance in patients with severe hypercholesterolemia.
    Leibovitz E; Hazanov N; Zimlichman R; Shargorodsky M; Gavish D
    Am J Hypertens; 2001 Nov; 14(11 Pt 1):1096-8. PubMed ID: 11724206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CYP3A4 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin in primary hypercholesterolemia.
    Kajinami K; Brousseau ME; Ordovas JM; Schaefer EJ
    Am J Cardiol; 2004 Jan; 93(1):104-7. PubMed ID: 14697480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes.
    Jinnouchi Y; Yamagishi S; Takeuchi M; Ishida S; Jinnouchi Y; Jinnouchi J; Imaizumi T
    Clin Exp Med; 2006 Dec; 6(4):191-3. PubMed ID: 17191111
    [No Abstract]   [Full Text] [Related]  

  • 35. [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?].
    Weizel A; Sawicki PT
    MMW Fortschr Med; 2004 Dec; 146(51-52):14, 16. PubMed ID: 15675236
    [No Abstract]   [Full Text] [Related]  

  • 36. [Regarding LDL cholesterol: the lower, the better (interview by Dr. Dirk Einecke)].
    Nissen S
    MMW Fortschr Med; 2004 Mar; 146(13):65. PubMed ID: 15219143
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.
    Davidson M; McKenney J; Stein E; Schrott H; Bakker-Arkema R; Fayyad R; Black D
    Am J Cardiol; 1997 Jun; 79(11):1475-81. PubMed ID: 9185636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of atorvastatin on hematologic parameters in patients with hypercholesterolemia.
    Akin F; Ayça B; Köse N; Sahin I; Akin MN; Canbek TD; Güngör O
    Angiology; 2013 Nov; 64(8):621-5. PubMed ID: 23460112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatment.
    Stulc T; Malbohan I; Malík J; Fialová L; Soukupová J; Ceska R
    Am Heart J; 2003 Dec; 146(6):E21. PubMed ID: 14661010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.